Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancer

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

2000 • 15,583 citations

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

2004 • 4,992 citations

Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

2004 • 1,709 citations

Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry

2005 • 1,081 citations

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

2005 • 948 citations

Immunohistochemical Detection of EGFR in Paraffin-embedded Tumor Tissues

2004 • 320 citations

Epidermal Growth Factor Receptor (EGFR) Status in Primary Colorectal Tumors Does Not Correlate With EGFR Expression in Related Metastatic Sites: Implications for Treatment With EGFR-Targeted Monoclonal Antibodies

2004 • 259 citations

Molecular Determinants of Cetuximab Efficacy

2005 • 233 citations

Pharmacological background of EGFR targeting

2004 • 104 citations

Activity of cetuximab in patients with colorectal cancer refractory to both irinotecan and oxaliplatin

2004 • 95 citations

Cetuximab in Previously Treated Colorectal Cancer

2005 • 9 citations

[Pharmacological skills for targeting EGFR and VEGF].

2005 • 7 citations